474 related articles for article (PubMed ID: 36012243)
21. Ginkgolide B inhibits NLRP3 inflammasome activation and promotes microglial M2 polarization in Aβ
Zhang Y; Zhao Y; Zhang J; Gao Y; Li S; Chang C; Yu D; Yang G
Neurosci Lett; 2021 Nov; 764():136206. PubMed ID: 34478813
[TBL] [Abstract][Full Text] [Related]
22. ER stress associated TXNIP-NLRP3 inflammasome activation in hippocampus of human Alzheimer's disease.
Ismael S; Wajidunnisa ; Sakata K; McDonald MP; Liao FF; Ishrat T
Neurochem Int; 2021 Sep; 148():105104. PubMed ID: 34153352
[TBL] [Abstract][Full Text] [Related]
23. Myricetin improves pathological changes in 3×Tg-AD mice by regulating the mitochondria-NLRP3 inflammasome-microglia channel by targeting P38 MAPK signaling pathway.
Liu P; Zhou Y; Shi J; Wang F; Yang X; Zheng X; Wang Y; He Y; Xie X; Pang X
Phytomedicine; 2023 Jul; 115():154801. PubMed ID: 37086707
[TBL] [Abstract][Full Text] [Related]
24. Tau induces inflammasome activation and microgliosis through acetylating NLRP3.
Zhang L; Gai Y; Liu Y; Meng D; Zeng Y; Luo Y; Zhang H; Wang Z; Yang M; Li Y; Liu Y; Lai Y; Yang J; Wu G; Chen Y; Zhu J; Liu S; Yu T; Zeng J; Wang J; Zhu D; Wang X; Lan X; Liu R
Clin Transl Med; 2024 Mar; 14(3):e1623. PubMed ID: 38488468
[TBL] [Abstract][Full Text] [Related]
25. NLRP3 and Infections: β-Amyloid in Inflammasome beyond Neurodegeneration.
Sita G; Graziosi A; Hrelia P; Morroni F
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34209586
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's Disease: New Concepts on the Role of Autoimmunity and NLRP3 Inflammasome in the Pathogenesis of the Disease.
Severini C; Barbato C; Di Certo MG; Gabanella F; Petrella C; Di Stadio A; de Vincentiis M; Polimeni A; Ralli M; Greco A
Curr Neuropharmacol; 2021; 19(4):498-512. PubMed ID: 32564756
[TBL] [Abstract][Full Text] [Related]
27. Alterations in the Gut-Microbial-Inflammasome-Brain Axis in a Mouse Model of Alzheimer's Disease.
Shukla PK; Delotterie DF; Xiao J; Pierre JF; Rao R; McDonald MP; Khan MM
Cells; 2021 Apr; 10(4):. PubMed ID: 33916001
[TBL] [Abstract][Full Text] [Related]
28. Activation of NLRP3 Inflammasome and Onset of Alzheimer's Disease.
Bai H; Zhang Q
Front Immunol; 2021; 12():701282. PubMed ID: 34381452
[TBL] [Abstract][Full Text] [Related]
29. The neuroprotection of progesterone against Aβ-induced NLRP3-Caspase-1 inflammasome activation via enhancing autophagy in astrocytes.
Hong Y; Liu Y; Yu D; Wang M; Hou Y
Int Immunopharmacol; 2019 Sep; 74():105669. PubMed ID: 31176046
[TBL] [Abstract][Full Text] [Related]
30. A
Merighi S; Nigro M; Travagli A; Pasquini S; Borea PA; Varani K; Vincenzi F; Gessi S
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563447
[TBL] [Abstract][Full Text] [Related]
31. NLRP3 Inflammasome Blocking as a Potential Treatment of Central Insulin Resistance in Early-Stage Alzheimer's Disease.
Komleva YK; Potapenko IV; Lopatina OL; Gorina YV; Chernykh A; Khilazheva ED; Salmina AB; Shuvaev AN
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34769018
[TBL] [Abstract][Full Text] [Related]
32. A novel strategy for bioactive natural products targeting NLRP3 inflammasome in Alzheimer's disease.
Yang Z; Liu J; Wei S; Deng J; Feng X; Liu S; Liu M
Front Pharmacol; 2022; 13():1077222. PubMed ID: 36699095
[TBL] [Abstract][Full Text] [Related]
33. Kainic acid Induces production and aggregation of amyloid β-protein and memory deficits by activating inflammasomes in NLRP3- and NF-κB-stimulated pathways.
Ruan Y; Qiu X; Lv YD; Dong D; Wu XJ; Zhu J; Zheng XY
Aging (Albany NY); 2019 Jun; 11(11):3795-3810. PubMed ID: 31182681
[TBL] [Abstract][Full Text] [Related]
34. Inflammasome NLRP3 Potentially Links Obesity-Associated Low-Grade Systemic Inflammation and Insulin Resistance with Alzheimer's Disease.
Litwiniuk A; Bik W; Kalisz M; Baranowska-Bik A
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070553
[TBL] [Abstract][Full Text] [Related]
35. NLRP3 inflammasome activation drives tau pathology.
Ising C; Venegas C; Zhang S; Scheiblich H; Schmidt SV; Vieira-Saecker A; Schwartz S; Albasset S; McManus RM; Tejera D; Griep A; Santarelli F; Brosseron F; Opitz S; Stunden J; Merten M; Kayed R; Golenbock DT; Blum D; Latz E; Buée L; Heneka MT
Nature; 2019 Nov; 575(7784):669-673. PubMed ID: 31748742
[TBL] [Abstract][Full Text] [Related]
36. MCC950 reduces autophagy and improves cognitive function by inhibiting NLRP3-dependent neuroinflammation in a rat model of Alzheimer's disease.
Naeem A; Prakash R; Kumari N; Ali Khan M; Quaiyoom Khan A; Uddin S; Verma S; Ab Robertson A; Boltze J; Shadab Raza S
Brain Behav Immun; 2024 Feb; 116():70-84. PubMed ID: 38040385
[TBL] [Abstract][Full Text] [Related]
37. NLRP3 Inflammasome: An Emerging Therapeutic Target for Alzheimer's Disease.
Tao S; Fan W; Liu J; Wang T; Zheng H; Qi G; Chen Y; Zhang H; Guo Z; Zhou F
J Alzheimers Dis; 2023; 96(4):1383-1398. PubMed ID: 37980662
[TBL] [Abstract][Full Text] [Related]
38. Modulation of MAPK- and PI3/AKT-Dependent Autophagy Signaling by Stavudine (D4T) in PBMC of Alzheimer's Disease Patients.
La Rosa F; Zoia CP; Bazzini C; Bolognini A; Saresella M; Conti E; Ferrarese C; Piancone F; Marventano I; Galimberti D; Fenoglio C; Scarpini E; Clerici M
Cells; 2022 Jul; 11(14):. PubMed ID: 35883623
[TBL] [Abstract][Full Text] [Related]
39. The role of melatonin in amyloid beta-induced inflammation mediated by inflammasome signaling in neuronal cell lines.
Nopparat C; Boontor A; Kutpruek S; Govitrapong P
Sci Rep; 2023 Oct; 13(1):17841. PubMed ID: 37857668
[TBL] [Abstract][Full Text] [Related]
40. Lychee seed polyphenol inhibits Aβ-induced activation of NLRP3 inflammasome via the LRP1/AMPK mediated autophagy induction.
Qiu WQ; Pan R; Tang Y; Zhou XG; Wu JM; Yu L; Law BY; Ai W; Yu CL; Qin DL; Wu AG
Biomed Pharmacother; 2020 Oct; 130():110575. PubMed ID: 32768883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
